カテゴリ： 世界, 医療/バイオ, Market Monitor Global

ナノテクノロジードラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム医薬品、脂質ナノ粒子医薬品

■ 英語タイトル：Nanotechnology-based Drug Delivery Systems Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC16487）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC16487
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：118
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ナノテクノロジードラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム医薬品、脂質ナノ粒子医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のナノテクノロジードラッグデリバリーシステム市場規模と予測を収録しています。・世界のナノテクノロジードラッグデリバリーシステム市場：売上、2018年-2023年、2024年-2029年
・世界のナノテクノロジードラッグデリバリーシステム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のナノテクノロジードラッグデリバリーシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リポソーム医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ナノテクノロジードラッグデリバリーシステムのグローバル主要企業は、Johnson & Johnson、 Sun Pharmaceutical、 CSPC、 Kinyond、 Teva、 Fudan-Zhangjiang、 Zydus Cadila、 TTY Biopharma、 Pacira、 Luye Pharma、 Leadiant Biosciences、 Ipsen、 Sayre Therapeutics、 Jazz、 Alnylam、 Bausch Health、 Acrotech Biopharma、 Takeda、 Chiesi Farmaceutici、 Gilead Sciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ナノテクノロジードラッグデリバリーシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のナノテクノロジードラッグデリバリーシステム市場：タイプ別、2018年-2023年、2024年-2029年
世界のナノテクノロジードラッグデリバリーシステム市場：タイプ別市場シェア、2022年
・リポソーム医薬品、脂質ナノ粒子医薬品

世界のナノテクノロジードラッグデリバリーシステム市場：用途別、2018年-2023年、2024年-2029年
世界のナノテクノロジードラッグデリバリーシステム市場：用途別市場シェア、2022年
・病院、小売薬局、その他

世界のナノテクノロジードラッグデリバリーシステム市場：地域・国別、2018年-2023年、2024年-2029年
世界のナノテクノロジードラッグデリバリーシステム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるナノテクノロジードラッグデリバリーシステムのグローバル売上、2018年-2023年
・主要企業におけるナノテクノロジードラッグデリバリーシステムのグローバル売上シェア、2022年
・主要企業におけるナノテクノロジードラッグデリバリーシステムのグローバル販売量、2018年-2023年
・主要企業におけるナノテクノロジードラッグデリバリーシステムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson & Johnson、 Sun Pharmaceutical、 CSPC、 Kinyond、 Teva、 Fudan-Zhangjiang、 Zydus Cadila、 TTY Biopharma、 Pacira、 Luye Pharma、 Leadiant Biosciences、 Ipsen、 Sayre Therapeutics、 Jazz、 Alnylam、 Bausch Health、 Acrotech Biopharma、 Takeda、 Chiesi Farmaceutici、 Gilead Sciences

*************************************************************

・調査・分析レポートの概要
ナノテクノロジードラッグデリバリーシステム市場の定義
市場セグメント
世界のナノテクノロジードラッグデリバリーシステム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のナノテクノロジードラッグデリバリーシステム市場規模
世界のナノテクノロジードラッグデリバリーシステム市場規模：2022年 VS 2029年
世界のナノテクノロジードラッグデリバリーシステム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのナノテクノロジードラッグデリバリーシステムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のナノテクノロジードラッグデリバリーシステム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：リポソーム医薬品、脂質ナノ粒子医薬品
ナノテクノロジードラッグデリバリーシステムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、小売薬局、その他
ナノテクノロジードラッグデリバリーシステムの用途別グローバル売上・予測

・地域別市場分析
地域別ナノテクノロジードラッグデリバリーシステム市場規模 2022年と2029年
地域別ナノテクノロジードラッグデリバリーシステム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson、 Sun Pharmaceutical、 CSPC、 Kinyond、 Teva、 Fudan-Zhangjiang、 Zydus Cadila、 TTY Biopharma、 Pacira、 Luye Pharma、 Leadiant Biosciences、 Ipsen、 Sayre Therapeutics、 Jazz、 Alnylam、 Bausch Health、 Acrotech Biopharma、 Takeda、 Chiesi Farmaceutici、 Gilead Sciences
...

This research report provides a comprehensive analysis of the Nanotechnology-based Drug Delivery Systems market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nanotechnology-based Drug Delivery Systems market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nanotechnology-based Drug Delivery Systems, challenges faced by the industry, and potential opportunities for market players.
The global Nanotechnology-based Drug Delivery Systems market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nanotechnology-based Drug Delivery Systems market presents opportunities for various stakeholders, including Hospital, Retail Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nanotechnology-based Drug Delivery Systems market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nanotechnology-based Drug Delivery Systems market was valued at US$ 4733.8 million in 2022 and is projected to reach US$ 9568 million by 2029, at a CAGR of 10.5% during the forecast period.
The Nano-based Drug Delivery System Market is driven by the demand for more effective and targeted drug delivery methods. Nano-based systems offer improved drug solubility, bioavailability, and reduced side effects. However, a significant challenge is the complexity of nanotechnology and the need for rigorous safety assessments and regulatory approvals. Ensuring the safety and biocompatibility of nano-based drug delivery systems is crucial. Additionally, competition in the market and cost considerations pose challenges, necessitating a balance between affordability and the development of advanced nano-based drug delivery technologies to meet the evolving needs of the pharmaceutical industry while ensuring patient well-being.
Key Features:
The research report on the Nanotechnology-based Drug Delivery Systems market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nanotechnology-based Drug Delivery Systems market.
Market Overview: The report provides a comprehensive overview of the Nanotechnology-based Drug Delivery Systems market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Liposomes Drugs, Lipid Nanoparticle Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nanotechnology-based Drug Delivery Systems market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nanotechnology-based Drug Delivery Systems market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nanotechnology-based Drug Delivery Systems market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nanotechnology-based Drug Delivery Systems market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nanotechnology-based Drug Delivery Systems market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nanotechnology-based Drug Delivery Systems market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nanotechnology-based Drug Delivery Systems, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nanotechnology-based Drug Delivery Systems market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nanotechnology-based Drug Delivery Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs
Market segment by Application
Hospital
Retail Pharmacy
Other
Global Nanotechnology-based Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nanotechnology-based Drug Delivery Systems, market overview.
Chapter 2: Global Nanotechnology-based Drug Delivery Systems market size in revenue.
Chapter 3: Detailed analysis of Nanotechnology-based Drug Delivery Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nanotechnology-based Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Nanotechnology-based Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanotechnology-based Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanotechnology-based Drug Delivery Systems Overall Market Size
2.1 Global Nanotechnology-based Drug Delivery Systems Market Size: 2022 VS 2029
2.2 Global Nanotechnology-based Drug Delivery Systems Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nanotechnology-based Drug Delivery Systems Players in Global Market
3.2 Top Global Nanotechnology-based Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Nanotechnology-based Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Nanotechnology-based Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nanotechnology-based Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanotechnology-based Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Nanotechnology-based Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Nanotechnology-based Drug Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Nanotechnology-based Drug Delivery Systems Market Size Markets, 2022 & 2029
4.1.2 Liposomes Drugs
4.1.3 Lipid Nanoparticle Drugs
4.2 By Type – Global Nanotechnology-based Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type – Global Nanotechnology-based Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type – Global Nanotechnology-based Drug Delivery Systems Revenue, 2024-2029
4.2.3 By Type – Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nanotechnology-based Drug Delivery Systems Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Nanotechnology-based Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application – Global Nanotechnology-based Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application – Global Nanotechnology-based Drug Delivery Systems Revenue, 2024-2029
5.2.3 By Application – Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Nanotechnology-based Drug Delivery Systems Market Size, 2022 & 2029
6.2 By Region – Global Nanotechnology-based Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region – Global Nanotechnology-based Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region – Global Nanotechnology-based Drug Delivery Systems Revenue, 2024-2029
6.2.3 By Region – Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Nanotechnology-based Drug Delivery Systems Revenue, 2018-2029
6.3.2 US Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.3.3 Canada Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.3.4 Mexico Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Nanotechnology-based Drug Delivery Systems Revenue, 2018-2029
6.4.2 Germany Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.4.3 France Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.4.4 U.K. Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.4.5 Italy Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.4.6 Russia Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.4.7 Nordic Countries Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.4.8 Benelux Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Nanotechnology-based Drug Delivery Systems Revenue, 2018-2029
6.5.2 China Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.5.3 Japan Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.5.4 South Korea Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.5.5 Southeast Asia Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.5.6 India Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Nanotechnology-based Drug Delivery Systems Revenue, 2018-2029
6.6.2 Brazil Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.6.3 Argentina Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Nanotechnology-based Drug Delivery Systems Revenue, 2018-2029
6.7.2 Turkey Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.7.3 Israel Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.7.4 Saudi Arabia Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
6.7.5 UAE Nanotechnology-based Drug Delivery Systems Market Size, 2018-2029
7 Nanotechnology-based Drug Delivery Systems Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.1.4 Johnson & Johnson Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Company Summary
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.2.4 Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.2.5 Sun Pharmaceutical Key News & Latest Developments
7.3 CSPC
7.3.1 CSPC Company Summary
7.3.2 CSPC Business Overview
7.3.3 CSPC Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.3.4 CSPC Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.3.5 CSPC Key News & Latest Developments
7.4 Kinyond
7.4.1 Kinyond Company Summary
7.4.2 Kinyond Business Overview
7.4.3 Kinyond Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.4.4 Kinyond Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.4.5 Kinyond Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.5.4 Teva Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Fudan-Zhangjiang
7.6.1 Fudan-Zhangjiang Company Summary
7.6.2 Fudan-Zhangjiang Business Overview
7.6.3 Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.6.4 Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.6.5 Fudan-Zhangjiang Key News & Latest Developments
7.7 Zydus Cadila
7.7.1 Zydus Cadila Company Summary
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.7.4 Zydus Cadila Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.7.5 Zydus Cadila Key News & Latest Developments
7.8 TTY Biopharma
7.8.1 TTY Biopharma Company Summary
7.8.2 TTY Biopharma Business Overview
7.8.3 TTY Biopharma Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.8.4 TTY Biopharma Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.8.5 TTY Biopharma Key News & Latest Developments
7.9 Pacira
7.9.1 Pacira Company Summary
7.9.2 Pacira Business Overview
7.9.3 Pacira Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.9.4 Pacira Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.9.5 Pacira Key News & Latest Developments
7.10 Luye Pharma
7.10.1 Luye Pharma Company Summary
7.10.2 Luye Pharma Business Overview
7.10.3 Luye Pharma Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.10.4 Luye Pharma Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.10.5 Luye Pharma Key News & Latest Developments
7.11 Leadiant Biosciences
7.11.1 Leadiant Biosciences Company Summary
7.11.2 Leadiant Biosciences Business Overview
7.11.3 Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.11.4 Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.11.5 Leadiant Biosciences Key News & Latest Developments
7.12 Ipsen
7.12.1 Ipsen Company Summary
7.12.2 Ipsen Business Overview
7.12.3 Ipsen Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.12.4 Ipsen Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.12.5 Ipsen Key News & Latest Developments
7.13 Sayre Therapeutics
7.13.1 Sayre Therapeutics Company Summary
7.13.2 Sayre Therapeutics Business Overview
7.13.3 Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.13.4 Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.13.5 Sayre Therapeutics Key News & Latest Developments
7.14 Jazz
7.14.1 Jazz Company Summary
7.14.2 Jazz Business Overview
7.14.3 Jazz Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.14.4 Jazz Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.14.5 Jazz Key News & Latest Developments
7.15 Alnylam
7.15.1 Alnylam Company Summary
7.15.2 Alnylam Business Overview
7.15.3 Alnylam Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.15.4 Alnylam Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.15.5 Alnylam Key News & Latest Developments
7.16 Bausch Health
7.16.1 Bausch Health Company Summary
7.16.2 Bausch Health Business Overview
7.16.3 Bausch Health Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.16.4 Bausch Health Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.16.5 Bausch Health Key News & Latest Developments
7.17 Acrotech Biopharma
7.17.1 Acrotech Biopharma Company Summary
7.17.2 Acrotech Biopharma Business Overview
7.17.3 Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.17.4 Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.17.5 Acrotech Biopharma Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.18.4 Takeda Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.18.5 Takeda Key News & Latest Developments
7.19 Chiesi Farmaceutici
7.19.1 Chiesi Farmaceutici Company Summary
7.19.2 Chiesi Farmaceutici Business Overview
7.19.3 Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.19.4 Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.19.5 Chiesi Farmaceutici Key News & Latest Developments
7.20 Gilead Sciences
7.20.1 Gilead Sciences Company Summary
7.20.2 Gilead Sciences Business Overview
7.20.3 Gilead Sciences Nanotechnology-based Drug Delivery Systems Major Product Offerings
7.20.4 Gilead Sciences Nanotechnology-based Drug Delivery Systems Revenue in Global Market (2018-2023)
7.20.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Nanotechnology-based Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Nanotechnology-based Drug Delivery Systems Market Drivers in Global Market
Table 3. Nanotechnology-based Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Nanotechnology-based Drug Delivery Systems in Global Market
Table 5. Top Nanotechnology-based Drug Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nanotechnology-based Drug Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nanotechnology-based Drug Delivery Systems Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nanotechnology-based Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Nanotechnology-based Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanotechnology-based Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Nanotechnology-based Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nanotechnology-based Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Nanotechnology-based Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nanotechnology-based Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Nanotechnology-based Drug Delivery Systems Product Offerings
Table 32. Johnson & Johnson Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Sun Pharmaceutical Company Summary
Table 35. Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Product Offerings
Table 36. Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 37. Sun Pharmaceutical Key News & Latest Developments
Table 38. CSPC Company Summary
Table 39. CSPC Nanotechnology-based Drug Delivery Systems Product Offerings
Table 40. CSPC Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 41. CSPC Key News & Latest Developments
Table 42. Kinyond Company Summary
Table 43. Kinyond Nanotechnology-based Drug Delivery Systems Product Offerings
Table 44. Kinyond Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 45. Kinyond Key News & Latest Developments
Table 46. Teva Company Summary
Table 47. Teva Nanotechnology-based Drug Delivery Systems Product Offerings
Table 48. Teva Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Key News & Latest Developments
Table 50. Fudan-Zhangjiang Company Summary
Table 51. Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Product Offerings
Table 52. Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 53. Fudan-Zhangjiang Key News & Latest Developments
Table 54. Zydus Cadila Company Summary
Table 55. Zydus Cadila Nanotechnology-based Drug Delivery Systems Product Offerings
Table 56. Zydus Cadila Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 57. Zydus Cadila Key News & Latest Developments
Table 58. TTY Biopharma Company Summary
Table 59. TTY Biopharma Nanotechnology-based Drug Delivery Systems Product Offerings
Table 60. TTY Biopharma Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 61. TTY Biopharma Key News & Latest Developments
Table 62. Pacira Company Summary
Table 63. Pacira Nanotechnology-based Drug Delivery Systems Product Offerings
Table 64. Pacira Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 65. Pacira Key News & Latest Developments
Table 66. Luye Pharma Company Summary
Table 67. Luye Pharma Nanotechnology-based Drug Delivery Systems Product Offerings
Table 68. Luye Pharma Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 69. Luye Pharma Key News & Latest Developments
Table 70. Leadiant Biosciences Company Summary
Table 71. Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Product Offerings
Table 72. Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 73. Leadiant Biosciences Key News & Latest Developments
Table 74. Ipsen Company Summary
Table 75. Ipsen Nanotechnology-based Drug Delivery Systems Product Offerings
Table 76. Ipsen Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 77. Ipsen Key News & Latest Developments
Table 78. Sayre Therapeutics Company Summary
Table 79. Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Product Offerings
Table 80. Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 81. Sayre Therapeutics Key News & Latest Developments
Table 82. Jazz Company Summary
Table 83. Jazz Nanotechnology-based Drug Delivery Systems Product Offerings
Table 84. Jazz Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 85. Jazz Key News & Latest Developments
Table 86. Alnylam Company Summary
Table 87. Alnylam Nanotechnology-based Drug Delivery Systems Product Offerings
Table 88. Alnylam Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 89. Alnylam Key News & Latest Developments
Table 90. Bausch Health Company Summary
Table 91. Bausch Health Nanotechnology-based Drug Delivery Systems Product Offerings
Table 92. Bausch Health Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 93. Bausch Health Key News & Latest Developments
Table 94. Acrotech Biopharma Company Summary
Table 95. Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Product Offerings
Table 96. Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 97. Acrotech Biopharma Key News & Latest Developments
Table 98. Takeda Company Summary
Table 99. Takeda Nanotechnology-based Drug Delivery Systems Product Offerings
Table 100. Takeda Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 101. Takeda Key News & Latest Developments
Table 102. Chiesi Farmaceutici Company Summary
Table 103. Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Product Offerings
Table 104. Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 105. Chiesi Farmaceutici Key News & Latest Developments
Table 106. Gilead Sciences Company Summary
Table 107. Gilead Sciences Nanotechnology-based Drug Delivery Systems Product Offerings
Table 108. Gilead Sciences Nanotechnology-based Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 109. Gilead Sciences Key News & Latest Developments
List of Figures
Figure 1. Nanotechnology-based Drug Delivery Systems Segment by Type in 2022
Figure 2. Nanotechnology-based Drug Delivery Systems Segment by Application in 2022
Figure 3. Global Nanotechnology-based Drug Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nanotechnology-based Drug Delivery Systems Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nanotechnology-based Drug Delivery Systems Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nanotechnology-based Drug Delivery Systems Revenue in 2022
Figure 8. By Type - Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 9. By Application - Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 10. By Type - Global Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 12. By Application - Global Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 14. By Region - Global Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 15. By Country - North America Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 16. US Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 20. Germany Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 21. France Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 28. China Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 32. India Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 34. Brazil Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Nanotechnology-based Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 37. Turkey Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Nanotechnology-based Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 41. Johnson & Johnson Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. CSPC Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Kinyond Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Zydus Cadila Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. TTY Biopharma Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pacira Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Luye Pharma Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Ipsen Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Jazz Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Alnylam Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Bausch Health Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Takeda Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Gilead Sciences Nanotechnology-based Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注射用薬物送達システムのグローバル市場展望 2023年-2029年：充填済み注射器、自動注射器（シリンジ式およびカートリッジ式）、ペン型注射器、その他
  • 眼科用徐放性ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント
  • マイクロニードル媒介薬物送達パッチのグローバル市場展望 2023年-2029年：中空マイクロニードル技術、中実マイクロニードル技術、溶解マイクロニードル技術
  • 遺伝子治療薬送達チューブのグローバル市場展望 2023年-2029年：延長チューブタイプ、静脈カテーテルタイプ
  • 薬物送達用リポソームのグローバル市場展望 2023年-2029年：リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC16487 )"ナノテクノロジードラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム医薬品、脂質ナノ粒子医薬品" (英文：Nanotechnology-based Drug Delivery Systems Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。